Jazz Pharmaceuticals PLC (JAZZ)

Exchange
NASDAQ
Symbol
JAZZ
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    113.05
  • High
    114.12
  • Low
    110.63
  • Close
    111.55
  • Volume
    821,748

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.27
Receivables turnover
5.40
Payables turnover
19.00
Working capital turnover
2.01
Days of inventory on hand (DOH)
111.65
Days of sales outstanding (DSO)
67.62
Number of days of payables
19.21
Fixed asset turnover
23.06
Total asset turnover
0.33
 Liquidity ratios
Current ratio
2.24
Quick ratio
1.71
Cash ratio
1.25
Cash conversion cycle
160.05
 Solvency ratios
Debt-to-assets ratio
0.45
Debt-to-capital ratio
0.58
Debt-to-equity ratio
1.37
Financial leverage ratio
3.05
Interest coverage
1.87
 Profitability ratios
Gross profit margin
48.77%
Operating profit margin
15.19%
Pretax margin
7.74%
Net profit margin
10.89%
Operating return on assets (Operating ROA)
5.08%
Return on assets (ROA)
3.64%
Return on total capital
6.54%
Return on equity (ROE)
11.10%